Optical coherence tomography findings after an intravitreal injection of bevacizumab (avastin) for neovascular age-related macular degeneration.

@article{Rosenfeld2005OpticalCT,
  title={Optical coherence tomography findings after an intravitreal injection of bevacizumab (avastin) for neovascular age-related macular degeneration.},
  author={Philip J. Rosenfeld and Andrew A. Moshfeghi and Carmen A. Puliafito},
  journal={Ophthalmic surgery, lasers & imaging : the official journal of the International Society for Imaging in the Eye},
  year={2005},
  volume={36 4},
  pages={331-5}
}
To determine whether intravitreal bevacizumab could improve optical coherence tomography and visual acuity outcomes in a patient with neovascular age-related macular degeneration who was responding poorly to pegaptanib therapy, an intravitreal injection of bevacizumab (1.0 mg) was given. Within 1 week, optical coherence tomography revealed resolution of the subretinal fluid, resulting in a normal-appearing macular contour. The improved macular appearance was maintained for at least 4 weeks, and… CONTINUE READING